arrow
J

Joost Bart

University of Groningen
H指数:34
被引数:6,552

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of p53 immunohistochemistry can improve diagnostic agreement for differentiated vulvar intraepithelial neoplasia (dVIN): an international reproducibility study

p53免疫组化检测的应用可提高外阴分化型上皮内瘤变(dVIN)的诊断一致性:一项国际可重复性研究

2025-08-050
OAAI
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept study

APOLLO:原发性外阴鳞状细胞癌的新辅助帕博利珠单抗治疗——一项多中心、单臂、II期概念验证临床研究

2025-04-170
OAAI
Use of p53 Immunohistochemistry Can Improve Diagnostic Agreement for Differentiated Vulvar Intraepithelial Neoplasia (dVIN): An International Reproducibility Study
2025-03-010
PRE
Neo-Adjuvant Immune Checkpoint Inhibition In Endometrial Cancer Expands Transcriptional Footprints Associated With Tertiary Lymphoid Structures: Implications For Future Immunotherapy

新辅助免疫检查点抑制在子宫内膜癌中扩大与三级淋巴结构相关的转录印记:对未来免疫治疗的启示

2025-02-010
PRE
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers

BRCA1/2种系致病性变异携带者中降低风险的输卵管卵巢切除术后发生的高级别浆液性癌

2024-11-230
PRE
B cells critical for outcome in high grade serous ovarian carcinoma

B细胞对高级别浆液性卵巢癌的预后至关重要

2024-08-220
OAAI
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer
2024-03-010
OAAI
Variability in grading of ductal carcinoma in situ among an international group of pathologists

国际病理学家小组中导管原位癌分级的变异性

2021-02-2328
OAAI